$XNCR
Xencor, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Xencor, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is XNCR down today? It is at $33.24 (-2.21%), and our scanner flagged it 153 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment XNCR spikes, and full due diligence on XNCR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $XNCR 153 times in the last 30 days. Create a free account to track $XNCR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how XNCR traded in the last session, Friday (last price and move above). Our scanner fired 19 unusual-volume and momentum alerts on XNCR on Friday, peaking at 10.0x its normal volume.
Likely catalystXencor Inc: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 16, 2026 · 5 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cornelissen Bart Jan Officer | Sold (automatic/other) | -10K 0.01% of company | sold 13% | 66K | $402K at $39.82 | Nov 11, 26 |
Ranieri Richard J Director | Sold (automatic/other) | -81K 0.1% of company | sold 81% | 19K | $3.2M at $39.20 | Nov 10, 26 |
Ranieri Richard J Director | Other | 76K 0.1% of company | added 100% | 100K | $714K at $9.43 | Nov 10, 26 |
Feigal Ellen Director | Sold (automatic/other) | -7K | sold 36% | 12K | $89K at $13.06 | Jun 18, 26 |
Feigal Ellen Director | Acquired (grant/award) | +10K 0.01% of company | added 83% | 23K | n/a | Jun 16, 26 |
Deshaies Raymond Joseph Director | Acquired (grant/award) | +10K 0.01% of company | n/a | 10K | n/a | Jun 16, 26 |
Simpson Todd E Director | Acquired (grant/award) | +10K 0.01% of company | added 75% | 24K | n/a | Jun 16, 26 |
Ranieri Richard J Director | Acquired (grant/award) | +10K 0.01% of company | added 75% | 24K | n/a | Jun 16, 26 |
Montgomery Alan Bruce Director | Acquired (grant/award) | +10K 0.01% of company | added 66% | 26K | n/a | Jun 16, 26 |
Klencke Barbara Director | Acquired (grant/award) | +10K 0.01% of company | added 52% | 30K | n/a | Jun 16, 26 |
Gustafson Kurt A Director | Acquired (grant/award) | +10K 0.01% of company | added 70% | 25K | n/a | Jun 16, 26 |
Gorman Kevin Charles Director | Acquired (grant/award) | +10K 0.01% of company | added 91% | 22K | n/a | Jun 16, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how XNCR traded in the last session, Friday (last price and move above). Our scanner fired 19 unusual-volume and momentum alerts on XNCR on Friday, peaking at 10.0x its normal volume.
XNCR last traded at $33.24, down 2.21% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The XNCR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged XNCR 153 times in the last 30 days.
XNCR (Xencor, Inc.) trades on XNAS, with a market cap of about $2.50B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge XNCR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$XNCR discussion
Sign in to ask a question or join the discussion.